Related Experiment Video
Updated: Jun 8, 2026
08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
SOX10 expression in superficial spreading and nodular malignant melanomas
Margrét Agnarsdóttir1, Linda Sooman, Asa Bolander
1Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Sweden. margret.agnarsdottir@genpat.uu.se
Melanoma Research
|October 5, 2010
Summary
SOX10 protein expression is reduced in malignant melanoma, particularly in metastases. Lower SOX10 levels correlate with increased tumor stage and reduced survival, suggesting a role in melanoma progression.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- SOX10 is a crucial transcription factor in neural crest development, including melanocytes.
- Its role in malignant melanoma, a cancer of pigment-producing cells, requires further elucidation.
Purpose of the Study:
- To investigate SOX10 protein expression in malignant melanoma.
- To correlate SOX10 levels with clinical parameters, proliferation (Ki-67), and patient survival.
- To assess the impact of SOX10 downregulation on melanoma cell proliferation and migration in vitro.
Main Methods:
- Immunohistochemistry and tissue microarrays were used to analyze SOX10 expression in 106 primary melanomas, 39 metastases, 16 normal skin samples, and 6 benign nevi.
- Manual and automated algorithms evaluated staining intensity.
- SOX10 small interfering RNA (siRNA) was used to downregulate expression in melanoma cell lines.
Main Results:
- SOX10 was strongly expressed in benign tissues, with superficial spreading melanomas showing higher intensity than nodular types.
- SOX10 intensity inversely correlated with tumor T-stage and was significantly lower in metastases compared to primary tumors.
- Higher SOX10 intensity correlated with better overall survival and time to recurrence, though not in multivariate analysis.
- Automated analysis revealed an inverse correlation between SOX10 and Ki-67, a proliferation marker.
- SOX10 downregulation had variable effects on melanoma cell proliferation and migration.
Conclusions:
- SOX10 protein expression levels vary significantly across different tissue types and melanoma subtypes.
- SOX10 intensity is linked to melanoma progression and patient survival, suggesting its potential as a prognostic marker.
- The precise role of SOX10 in melanoma cell proliferation and migration in vitro remains inconclusive.
Related Concept Videos
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...